Pay in 4 interest-free payments of $6.44 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
JW Pharmaceutical (001060.KS) has moved to introduce a new glucagon-like peptide-1 (GLP-1) drug as part of its strategy to enter the obesity and diabetes treatment market
This makes it a triple agonist medication, the first of its kind
To date, however, its application to the oral mucosa has thus far been explored only in the context of improving xerostomia and salivary viscosity in patients undergoing treatment for head and neck cancer 21
Convenient Oral Dissolving Film
It helps to reduce the appearance of fine lines and wrinkles
Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors
US$ 22.86
US$ 20.62
US$ 22.66
US$ 22.55
US$ 21.93
